What birth control options are recommended for a patient with protein S deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Birth Control Recommendations for Protein S Deficiency

Women with protein S deficiency should use progestin-only intrauterine devices (IUDs) or copper IUDs as first-line contraception, and must strictly avoid all combined estrogen-progestin contraceptives due to significantly elevated thrombotic risk. 1

Primary Recommended Options

Levonorgestrel IUD (Preferred)

  • Provides the highest efficacy (<1% pregnancy rate annually) with no increased thrombotic risk in women with thrombophilia 1
  • Reduces menstrual bleeding, which is particularly beneficial if anticoagulation therapy is needed 2
  • Does not require daily adherence, eliminating user-dependent failure 1
  • Safe regardless of disease activity or other thrombotic risk factors 2

Copper IUD (Equally Safe Alternative)

  • Completely hormone-free option with equivalent contraceptive efficacy (<1% failure rate) 1
  • No hormonal effects on coagulation pathways 1
  • May increase menstrual bleeding, which could be problematic if anticoagulation is required 1

Progestin-Only Pills (Less Preferred)

  • Safe thrombotic profile in women with thrombophilia 1
  • Lower efficacy (5-8% failure rate) due to strict adherence requirements—must be taken at the same time daily 1
  • No increased venous thromboembolism risk (relative risk 0.90) 1

Absolutely Contraindicated Options

Combined Estrogen-Progestin Contraceptives (All Forms)

  • Protein S deficiency represents a severe thrombophilia that creates unacceptable thrombotic risk when combined with estrogen 3, 4
  • Women with protein S deficiency taking oral contraceptives have a 7-fold increased risk of venous thromboembolism compared to non-users 3
  • Absolute VTE risk reaches 4.3-4.6 per 100 pill-years in women with severe thrombophilia (including protein S deficiency) using combined contraceptives 3
  • Estrogen-containing contraceptives further decrease free protein S levels, compounding the existing deficiency 5, 6, 7
  • This prohibition includes all delivery methods: oral pills, transdermal patches, and vaginal rings 1, 8

Depot Medroxyprogesterone Acetate (DMPA)

  • Should be avoided due to higher VTE risk (relative risk 2.67) compared to other progestin-only methods 1
  • Thrombotic risk approaches that of combined oral contraceptives 1
  • Additional concern for bone mineral density loss with long-term use 1

Clinical Implementation Algorithm

Step 1: Confirm Diagnosis

  • Document protein S deficiency with laboratory testing before contraceptive counseling 3, 4
  • Assess for additional thrombotic risk factors (family history of VTE, personal history of thrombosis) 3

Step 2: First-Line Recommendation

  • Offer levonorgestrel IUD as optimal choice 1, 2
  • Explain <1% pregnancy rate and lack of thrombotic risk 1
  • Emphasize benefit of reduced menstrual bleeding if anticoagulation is present 2

Step 3: Alternative if IUD Declined

  • Copper IUD if patient prefers hormone-free option 1
  • Progestin-only pills if patient cannot tolerate IUD, with strong counseling about daily adherence requirements 1

Step 4: Barrier Methods as Adjunct

  • Recommend condoms for sexually transmitted infection protection regardless of primary method chosen 1

Critical Pitfalls to Avoid

  • Never prescribe combined hormonal contraceptives to women with protein S deficiency, even if they request it—the thrombotic risk is unacceptable 3, 4
  • Do not assume progestin implants are equivalent to other progestin-only methods—insufficient data exists for women with severe thrombophilia 1
  • Avoid DMPA despite being progestin-only due to its unique thrombogenic profile 1
  • Do not delay contraceptive counseling until after a thrombotic event occurs 3, 4

Emergency Contraception

  • Levonorgestrel emergency contraception (Plan B) is safe and not contraindicated in protein S deficiency 1
  • No medical contraindications exist for progestin-only emergency contraception 1
  • Risks of emergency contraception are substantially lower than risks of unintended pregnancy 1

Special Considerations

If Anticoagulation Required

  • Levonorgestrel IUD becomes even more advantageous due to menstrual bleeding reduction 2
  • Copper IUD may worsen bleeding in anticoagulated patients 1

If Pregnancy Desired in Future

  • IUDs are immediately reversible with rapid return to fertility upon removal 1
  • No delay in fertility restoration compared to barrier methods 1

References

Related Questions

What birth control is recommended for a patient with varicose veins in the arm?
Can patients with Factor V (Coagulation Factor V) mutation take combined oral contraceptive pills (COCs)?
Can a woman with Factor V Leiden take progestin-only (progestin) birth control pills?
Can protein S deficiency be tested for during pregnancy?
Does oral medroxyprogesterone (MPA) increase the risk of thrombosis?
What are the implications and management of a significantly elevated Blood Urea Nitrogen (BUN)/creatinine ratio of 60 in an older patient with a history of hypertension and diabetes?
What is the best course of action for a patient with poorly controlled hypertension, impaired renal function (GFR of 68, creatinine of 1.31), and an A1C of 5.8, who has stopped taking their prescribed antihypertensive medications, lisinopril (angiotensin-converting enzyme inhibitor) and HCTZ (hydrochlorothiazide, a diuretic), and is experiencing drowsiness after taking amoxicillin (an antibiotic)?
What are the contraindications to Menopausal Hormone Therapy (MHT) in a peri- or postmenopausal woman?
Is ketoconazole a suitable treatment option for a male patient with male pattern (androgenetic) alopecia?
What is the role of Upadacitinib (Janus kinase inhibitor) in treating inflammatory skin conditions, such as moderate to severe psoriasis or atopic dermatitis, in adult patients with inadequate response to conventional therapies?
Does a patient with impaired renal function, indicated by a glomerular filtration rate (GFR) of 68 and poorly controlled hypertension, require a urine microalbumin test to confirm Stage 2 Chronic Kidney Disease (CKD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.